Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1212–1226. doi: 10.1161/ATVBAHA.119.312729

Figure 1. IL-33 mediates thrombin-induced HASMC migration.

Figure 1.

A & B. RT-PCR and Western blot analysis of IL-33 and β-actin mRNA and protein levels, respectively, in control and various time periods of thrombin (0.5 U/ml)-treated HASMCs. C & D. The effects of normal IgG and neutralizing IL-33 antibody (100 ng/ml) on thrombin (0.5 U/ml)-induced HASMC migration and DNA synthesis. The bar graphs represent Mean ± S.D. values of three independent experiments. *, p < 0.05 versus control; **, p < 0.05 versus thrombin.